{"tid":2095105,"cid":5,"subCid":11,"title":"輝瑞新冠肺炎疫苗 初步人體試驗報捷","createTime":"2020-07-05T08:01:04.000Z","updateTime":"2020-07-05T10:32:29.000Z","uid":43041,"like":7,"dislike":1,"uniUserReply":7,"replies":[{"pid":"a771a3d22f88a81ecb26407c98af41497c304016","tid":2095105,"uid":43041,"like":0,"dislike":0,"score":0,"citedBy":1,"replyTime":"2020-07-05T08:01:04.000Z","msg":"疫苗來了<img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><br />\n<br />\n美國製藥大廠輝瑞（Pfizer）新冠肺炎疫苗初步人體試驗結果報捷，消息發布後，輝瑞股價1日早盤大漲5.6%，並推升美股早盤開高走高，道瓊指數一度上揚逾200點。<br />\n<br />\n輝瑞和德國製藥商BioNTech 共同開發mRNA實驗疫苗，第一階段臨床試驗的受試者共有45人，每位受試者分別接種10、30及100微克劑量的疫苗或安慰劑。<br />\n<br />\n根據研究人員的初步數據顯示，所有施打10或30微克劑量疫苗的參與者，在28天後體內均產生針對Covid-19的中和抗體。<br />\n<br />\n被視為人體遺傳密碼的mRNA（messenger RNA），是幫助細胞建構不同功能的藍圖傳遞者，在疫苗中作為抗原，負責誘導人體對新冠病毒產生免疫反應。<br />\n<br />\n輝瑞表示，這種疫苗通常耐受性良好，但其實驗性疫苗也會導致某些受試者發燒，特別是對於100毫克組的受試者。<br />\n<br />\n這項試驗正面結果顯示，受試者施打疫苗後安全且生成更多對抗病毒的新抗體，成為最有希望的新冠候選疫苗。"},{"pid":"cfe3890db4e5d956310ab3de2af3e04028963c30","tid":2095105,"uid":6566,"like":2,"dislike":2,"score":0,"quote":{"pid":"a771a3d22f88a81ecb26407c98af41497c304016","tid":2095105,"uid":43041,"like":0,"dislike":0,"score":0,"citedBy":1,"replyTime":"2020-07-05T08:01:04.000Z","msg":"疫苗來了<img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><br />\n<br />\n美國製藥大廠輝瑞（Pfizer）新冠肺炎疫苗初步人體試驗結果報捷，消息發布後，輝瑞股價1日早盤大漲5.6%，並推升美股早盤開高走高，道瓊指數一度上揚逾200點。<br />\n<br />\n輝瑞和德國製藥商BioNTech 共同開發mRNA實驗疫苗，第一階段臨床試驗的受試者共有45人，每位受試者分別接種10、30及100微克劑量的疫苗或安慰劑。<br />\n<br />\n根據研究人員的初步數據顯示，所有施打10或30微克劑量疫苗的參與者，在28天後體內均產生針對Covid-19的中和抗體。<br />\n<br />\n被視為人體遺傳密碼的mRNA（messenger RNA），是幫助細胞建構不同功能的藍圖傳遞者，在疫苗中作為抗原，負責誘導人體對新冠病毒產生免疫反應。<br />\n<br />\n輝瑞表示，這種疫苗通常耐受性良好，但其實驗性疫苗也會導致某些受試者發燒，特別是對於100毫克組的受試者。<br />\n<br />\n這項試驗正面結果顯示，受試者施打疫苗後安全且生成更多對抗病毒的新抗體，成為最有希望的新冠候選疫苗。"},"citedBy":1,"replyTime":"2020-07-05T08:01:47.000Z","msg":"成個星期前既新聞都貼出黎"},{"pid":"ff4ab02c6873211cb44c8ca9f9833cee8a7e76bf","tid":2095105,"uid":43041,"like":1,"dislike":1,"score":0,"quote":{"pid":"cfe3890db4e5d956310ab3de2af3e04028963c30","tid":2095105,"uid":6566,"like":2,"dislike":2,"score":0,"quote":{"pid":"a771a3d22f88a81ecb26407c98af41497c304016","tid":2095105,"uid":43041,"like":0,"dislike":0,"score":0,"citedBy":1,"replyTime":"2020-07-05T08:01:04.000Z","msg":"疫苗來了<img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><br />\n<br />\n美國製藥大廠輝瑞（Pfizer）新冠肺炎疫苗初步人體試驗結果報捷，消息發布後，輝瑞股價1日早盤大漲5.6%，並推升美股早盤開高走高，道瓊指數一度上揚逾200點。<br />\n<br />\n輝瑞和德國製藥商BioNTech 共同開發mRNA實驗疫苗，第一階段臨床試驗的受試者共有45人，每位受試者分別接種10、30及100微克劑量的疫苗或安慰劑。<br />\n<br />\n根據研究人員的初步數據顯示，所有施打10或30微克劑量疫苗的參與者，在28天後體內均產生針對Covid-19的中和抗體。<br />\n<br />\n被視為人體遺傳密碼的mRNA（messenger RNA），是幫助細胞建構不同功能的藍圖傳遞者，在疫苗中作為抗原，負責誘導人體對新冠病毒產生免疫反應。<br />\n<br />\n輝瑞表示，這種疫苗通常耐受性良好，但其實驗性疫苗也會導致某些受試者發燒，特別是對於100毫克組的受試者。<br />\n<br />\n這項試驗正面結果顯示，受試者施打疫苗後安全且生成更多對抗病毒的新抗體，成為最有希望的新冠候選疫苗。"},"citedBy":1,"replyTime":"2020-07-05T08:01:47.000Z","msg":"成個星期前既新聞都貼出黎"},"citedBy":0,"replyTime":"2020-07-05T08:02:47.000Z","msg":"錯，係最新新聞黎<img src=\"/assets/faces/normal/bomb.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/bomb.gif\" class=\"hkgmoji\" />好開心"},{"pid":"78bddfd8ef91179882418e58b2e00642c7bd7613","tid":2095105,"uid":289946,"like":0,"dislike":2,"score":-2,"citedBy":1,"replyTime":"2020-07-05T09:09:28.000Z","msg":"早幾日都叫最新?<img src=\"/assets/faces/pig/heard.gif\" class=\"hkgmoji\" />"},{"pid":"9d7acb1680e947e1e027414c884ea0b681e43b96","tid":2095105,"uid":199957,"like":0,"dislike":1,"score":-1,"citedBy":0,"replyTime":"2020-07-05T10:03:25.000Z","msg":"<img src=\"/assets/faces/lm2/lick.gif\" class=\"hkgmoji\" />"},{"pid":"e531fd177918306d9b62d1677d994e6398cfc864","tid":2095105,"uid":43041,"like":1,"dislike":1,"score":0,"quote":{"pid":"78bddfd8ef91179882418e58b2e00642c7bd7613","tid":2095105,"uid":289946,"like":0,"dislike":2,"score":-2,"citedBy":1,"replyTime":"2020-07-05T09:09:28.000Z","msg":"早幾日都叫最新?<img src=\"/assets/faces/pig/heard.gif\" class=\"hkgmoji\" />"},"citedBy":0,"replyTime":"2020-07-05T10:04:54.000Z","msg":"好新架<img src=\"/assets/faces/normal/biggrin.gif\" class=\"hkgmoji\" />"},{"pid":"daf2ab3b177315afa19fc90b0a5af66634aca6d2","tid":2095105,"uid":38316,"like":0,"dislike":2,"score":-2,"citedBy":1,"replyTime":"2020-07-05T10:29:52.000Z","msg":"會唔會攞嚟制裁中國<img src=\"/assets/faces/normal/sosad.gif\" class=\"hkgmoji\" />"},{"pid":"a054222d053754a6414aa8b0616b84edf39d1c08","tid":2095105,"uid":186882,"like":0,"dislike":1,"score":-1,"quote":{"pid":"daf2ab3b177315afa19fc90b0a5af66634aca6d2","tid":2095105,"uid":38316,"like":0,"dislike":2,"score":-2,"citedBy":1,"replyTime":"2020-07-05T10:29:52.000Z","msg":"會唔會攞嚟制裁中國<img src=\"/assets/faces/normal/sosad.gif\" class=\"hkgmoji\" />"},"citedBy":0,"replyTime":"2020-07-05T10:31:53.000Z","msg":"侵講明要中國付出代價，肯定唔會買大豆就算<img src=\"/assets/faces/dog/smile.gif\" class=\"hkgmoji\" />"},{"pid":"1e73e4cef95b4d2efc0521b7bce783f779e09386","tid":2095105,"uid":70786,"like":0,"dislike":2,"score":-2,"citedBy":0,"replyTime":"2020-07-05T10:32:29.000Z","msg":"美國又拯救地球<img src=\"/assets/faces/lm2/cry.gif\" class=\"hkgmoji\" />"}]}